Abacavir Sulfate: CAS Registry Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, is a potent HIV medication. It inhibits the replication of the human immunodeficiency virus (HIV) by interfering with the viral enzyme reverse transcriptase. This enzyme is essential in the HIV life cycle, allowing the virus to insert its genetic material into the host's DNA. Abacavir

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor administered in the therapy of human immunodeficiency virus infection. Its pharmacological properties rely on the selective inhibition of reverse transcriptase, an enzyme crucial for HIV replication. Abacavir sulfate is a pro-drug that experiences transformation to its active fo

read more

Premier API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for businesses of all sizes. The premier global API manufacturer and supplier offers a comprehensive selection of cutting-edge APIs designed to meet the diverse needs of modern applications. With a strong commitment to quality, innovation, and cust

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleotide reverse transcriptase inhibitor. Its mechanism of action involves the competitive inhibition of HIV-1 reverse transcriptase, an enzyme crucial for ALARELIN ACETATE 79561-22-1 viral replication. Abacavir sulfate exerts its effects by being incorporated into the growing DNA chain during reverse transcription, leading

read more

The Top Nutraceutical API Supplier

India has firmly established itself as a global hub for dietary supplement ingredient creation, particularly in the realm of Active Pharmaceutical Ingredients (active ingredients). Numerous domestic firms specialize in the contract production of wellness APIs, serving both the local market and exporting globally. These firms boast advanced faciliti

read more